Diller LR - Search Results

1

Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition.

MacFarland SP, Maese L, Rednam SP, Kamihara J, Perrino MR, Nichols KE, Brodeur GM, Schiffman JD, Plon SE, Diller LR, Malkin D, Porter CC, Villani A. MacFarland SP, et al. Among authors: diller lr. Cancer Prev Res (Phila). 2022 Oct 4;15(10):645-652. doi: 10.1158/1940-6207.CAPR-22-0215. Cancer Prev Res (Phila). 2022. PMID: 36001348

2

Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Diller L, Sexsmith E, Gottlieb A, Li FP, Malkin D. Diller L, et al. J Clin Invest. 1995 Apr;95(4):1606-11. doi: 10.1172/JCI117834. J Clin Invest. 1995. PMID: 7706467 Free PMC article.

3

Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.

Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM. Cheng JM, et al. Prog Clin Biol Res. 1994;385:43-9. Prog Clin Biol Res. 1994. PMID: 7972236

4

Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.

Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM. Cheng JM, et al. Nat Genet. 1993 Jun;4(2):191-4. doi: 10.1038/ng0693-191. Nat Genet. 1993. PMID: 8102299

5

Childhood cancer predisposition: applications of molecular testing and future implications.

Nichols KE, Li FP, Haber DA, Diller L. Nichols KE, et al. J Pediatr. 1998 Mar;132(3 Pt 1):389-97. doi: 10.1016/s0022-3476(98)70007-1. J Pediatr. 1998. PMID: 9544888 Review. No abstract available.

6

Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.

Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L. Nichols KE, et al. J Clin Oncol. 1999 Apr;17(4):1259. doi: 10.1200/JCO.1999.17.4.1259. J Clin Oncol. 1999. PMID: 10561187

7

Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.

Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Malkin D, et al. Oncogene. 2001 Jul 27;20(33):4441-9. doi: 10.1038/sj.onc.1204583. Oncogene. 2001. PMID: 11494139

8

TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.

Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L. Nichols KE, et al. J Clin Oncol. 2003 Dec 15;21(24):4505-9. doi: 10.1200/JCO.2003.12.042. J Clin Oncol. 2003. PMID: 14673037

9

Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.

George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT. George RE, et al. J Clin Oncol. 2005 Sep 20;23(27):6466-73. doi: 10.1200/JCO.2005.05.582. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116152 Clinical Trial.

10

Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Hettmer S, Archer NM, Somers GR, Novokmet A, Wagers AJ, Diller L, Rodriguez-Galindo C, Teot LA, Malkin D. Hettmer S, et al. Cancer. 2014 Apr 1;120(7):1068-75. doi: 10.1002/cncr.28507. Epub 2013 Dec 30. Cancer. 2014. PMID: 24382691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters